Between October and November, Brazil’s pink and blue ribbons flood clinics, workplaces, and family lunch tables — and this year they are doing exactly what they were designed to do: pushing people who feel perfectly healthy into doctors’ offices. JM Online reported this week that two recurring patient stories capture why: a 42-year-old teacher whose mother had breast cancer at 46, and a 63-year-old farmer whose prostate cancer was found only because a blood test finally caught up with fifteen years of avoided checkups. Neither felt a thing.
That is the central public health reality of the 2026 awareness season: breast and prostate cancers — projected by Brazil’s National Cancer Institute (INCA) at roughly 78,600 and 77,900 new cases per year between 2026 and 2028 — are most treatable when found before symptoms appear, and both campaigns exist to break the silence that keeps people away until it is late.
Awareness Campaigns Spark Screenings
- Feeling fine is not the same as being screened — both cancers can grow silently for years, which is why exams matter even without symptoms.
- The ribbons are a door, not the room — campaigns get you to the appointment, but a real medical evaluation, including blood pressure and glucose checks, is what turns awareness into protection.
JM Online’s account makes the mechanism concrete. Cláudia, the teacher, assumed mammography was “something for after 50” — her exact words to the doctor: “I thought it was something for after 50, doctor.” A small lesion confined to the breast was found and treated early with breast-preserving surgery. Seu Antônio never had a prostate exam and insisted he felt nothing; his PSA blood test came back abnormal and a biopsy confirmed a localized tumor with a real chance of cure.
JM Online notes that some breast and prostate cancers are linked to inherited alterations in genes such as BRCA1 and BRCA2 — and that the same alterations can raise a man's risk of prostate, pancreatic, and even male breast cancer. Not everyone needs genetic testing, but everyone should be asked about their family.
The Brazilian Society of Urology advises men to discuss PSA testing and prostate examination from age 50 — or from 45 for those with a family history or who are Black — as a shared decision with the physician.
The Numbers Behind the Ribbons — and What They Hide
INCA’s 2026–2028 estimates give the campaigns their scale: excluding non-melanoma skin cancer, breast cancer accounts for about 30% of tumors in women and prostate cancer for roughly 30% in men. In Minas Gerais alone, the projection is 10,290 prostate and 8,430 breast cases per year. BS9 adds an access dimension: in 2025 alone, mobile units performed 60,831 mammograms across 117 municipalities — a 76% increase over the prior year — and more than 120,000 women were served in 253 cities between 2023 and 2025.
| Indicator | Figure | Source |
|---|---|---|
| New breast cancer cases per year in Brazil, 2026–2028 | ~78,600 | INCA, cited by JM Online and O Globo |
| New prostate cancer cases per year in Brazil, 2026–2028 | ~77,900 | INCA, cited by JM Online |
| Projected annual cases in Minas Gerais (prostate / breast) | 10,290 / 8,430 | INCA, cited by JM Online |
| Mammograms by mobile units in 2025 (117 municipalities) | 60,831 (+76% vs. prior year) | BS9, citing state program data |
The same sources also document the limits of awareness. BS9’s reporting on four women — including Laís Gonçalves, diagnosed at 35 with a toddler, and Lucimar “Lucy” Santos, who began chemotherapy in September 2021 and lost her mother two days later — shows that breast cancer does not wait for the “right” age, and that treatment unfolds alongside ordinary life. Blog do PAULO MELO profiles four patients at Hospital Anchieta, including geologist Edileuza de Melo Nogueira, 64, who summarized her resolve: “I didn’t come into this life to lose.” Susan Neville, 51, was diagnosed in May 2025 after feeling a lump in February, started treatment 13 days after biopsy, and had a mastectomy scheduled for November 4 — while still planning a Carnival trip to Salvador. “There is life beyond cancer,” she said.
When Campaigns Meet the Clinic: Reconstruction, Rights, and Support
JM Online highlights Uberaba’s À Flor da Pele project, born at Hospital Hélio Angotti to run breast reconstruction campaigns for women who lost a breast to cancer; it became an institute and has taken its campaigns to other states. Notícias Adventistas describes the human layer of that support: at a congress in Espírito Santo, volunteers delivered handmade scarves and heart-shaped pillows to AFECC, an organization serving women in oncology treatment, with Sandra Storch — whose 2023 self-exam discovery changed her life — now urging other women to know their bodies and not skip exams.
A Supplement Under Scrutiny During Chemotherapy
O Globo reports on the less visible side of treatment: fatigue, anemia, infections — actress Gabi Dallacostah was hospitalized in an ICU in October with a bacterial infection during breast cancer treatment — and a Brazilian clinical study now investigating whether a beta-glucan-based supplement, Biovit Bioglucan, can ease chemotherapy side effects. The trial, coordinated by the Liga Norte-Riograndense Contra o Câncer in Natal, will enroll at least 130 women aged 18+ with stage I–III HER2-negative breast cancer receiving chemotherapy before surgery, comparing the supplement against a placebo. Funding comes from the biopharmaceutical laboratory founded by Sam Silva, who says benefits are already observed in clinical practice — but the efficacy is not yet proven, and the supplement does not replace chemotherapy or any medically indicated care.
Discuss Supplements with Oncology Teams
Any supplement, including beta-glucan products, should be discussed with the oncology team before use during chemotherapy, since interactions and effects are still under study.
The Question the Ribbons Leave Open
December will take the ribbons off the storefronts; the disease will not take a holiday. What remains unanswered is how many of the people the campaigns reach this season will actually book the appointment, write down the family history, and complete the indicated exams — because, as JM Online concludes, nobody’s health should depend on luck.
References
- Instituto Nacional de Câncer (INCA) — 2026–2028 incidence estimates, as reported by JM Online, BS9, and O Globo
- Liga Norte-Riograndense Contra o Câncer — beta-glucan supplement trial during chemotherapy, as reported by O Globo
